Status
Conditions
Treatments
About
The goal of this project is to evaluate the effectiveness of a collaborative care model for primary care patients at Kaiser Permanente Colorado (KPCO) with depression and/or anxiety. Collaborative care uses evidence-based short-term treatments delivered to patients over the phone. We will explore the use of cost-efficient automated processes for patient outreach and follow-up, such as care pools of patients and using patient portal messaging, risk-based results routing to providers, and electronic health record (EHR) tools for patient tracking and outcome assessment. Using a cluster randomized design, we will compare results between clinics that are offering collaborative care to those that are not.
Full description
We will answer the question: does a collaborative care model in primary care clinics improve outcomes for patients with depression and/or anxiety? Specific components of the model include:
A cluster randomized design will be used to compare depression and anxiety outcomes for at least two randomly selected KPCO primary care clinics that implement collaborative care to those clinics that provide care as usual. This design will allow us to study the effectiveness of the collaborative care model and its potential for dissemination across Kaiser Permanente regions.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
18+
Current membership and active on patient portal
Depression Diagnosis in the prior year
Overdue for PHQ9 Screening based on the following criteria:
Anxiety diagnoses in the prior year
Has a baseline GAD7 in the same prior year; score = 10+ (*Note: Provider referrals could be GAD7 score of 7 or higher)
No Behavioral Health (BH) engagement in the prior year
Patient is not in a Skilled Nursing Facility or Hospice
Patient has no record of psychiatric hospitalization in the last year
Patient does not need an interpreter (i.e., English speaking)
Primary care location is one of the intervention clinics
Exclusion criteria
• Exclude individuals with any of the following diagnoses:
200 participants in 2 patient groups
Loading...
Central trial contact
Erica Morse, MA; Arne Beck, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal